Heterodimeric antibodies that bind somatostatin receptor 2
US11225521B2 · kind B2 · utility
8Cited by
122References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 24, 2019 |
| Grant date | Jan 18, 2022 |
| Priority date | — |
| Expiry date | Jul 16, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/73
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to antibodies, including novel antigen binding domains and heterodimeric antibodies, that bind somatostatin receptor 2 (SSTR2).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.